FEBUACE 40 (Febuxostat 40 mg)

FEBUACE 40 contains Febuxostat 40 mg, a xanthine oxidase inhibitor used for the long-term management of hyperuricemia (high uric acid levels) in patients with gout. It works by blocking the enzyme responsible for uric acid production, helping lower serum uric acid levels and reducing the formation of urate crystals. This action helps prevent recurrent gout attacks and supports better joint health over time.

FEBUACE 40 is commonly prescribed for adults with chronic hyperuricemia, especially those who require long-term uric acid control. Regular use under the supervision of a healthcare professional helps maintain target uric acid levels, reduces the frequency of gout flare-ups, and minimizes the risk of complications such as tophi and joint damage. Manufactured under stringent quality standards, FEBUACE 40 offers an effective and reliable treatment option for managing gout and promoting long-term joint health.

Key Benefits

• Helps lower elevated uric acid levels.
• Reduces the risk of recurrent gout attacks.
• Prevents urate crystal formation and deposition.
• Supports long-term gout management.
• Promotes better joint health and mobility.

Indications

• Hyperuricemia
• Chronic Gout
• Prevention of Recurrent Gout Attacks

Frequently Asked Questions

1. What is FEBUACE 40 used for?
FEBUACE 40 is used to lower high uric acid levels in adults with gout. It helps prevent gout attacks and supports long-term control of hyperuricemia.

2. How does Febuxostat work?
Febuxostat inhibits the xanthine oxidase enzyme, which is responsible for producing uric acid in the body. This helps reduce uric acid levels and prevents crystal formation in the joints.

3. Can FEBUACE 40 be taken for long-term treatment?
Yes. FEBUACE 40 is intended for long-term management of hyperuricemia and gout. It should be taken regularly as prescribed by a healthcare professional, with periodic monitoring of uric acid levels.